https://retacompare.com/news/retatrutide-s-fda-approval-anticipated-for-2026-in-weight-loss-sector 2026-10-19T03:19:21.000Z RetatrutideCompare en 2026-10-19T03:19:21.000Z Retatrutide's FDA Approval Anticipated for 2026 in Weight Loss Sector Market News, Retatrutide https://retacompare.com/news/glp-1-agonists-show-promise-in-improving-sleep-apnea-by-enhancing-breathing 2026-10-19T03:04:09.000Z RetatrutideCompare en 2026-10-19T03:04:09.000Z GLP-1 Agonists Show Promise in Improving Sleep Apnea by Enhancing Breathing Weight Loss, Retatrutide https://retacompare.com/news/emerging-weight-loss-drugs-retatrutide-and-cagrisema-by-2026 2026-10-19T02:07:30.000Z RetatrutideCompare en 2026-10-19T02:07:30.000Z Emerging Weight Loss Drugs: Retatrutide and Cagrisema by 2026 Weight Loss, Retatrutide https://retacompare.com/news/safety-of-glp-1-agonists-in-overweight-patients-undergoing-shoulder-surgery 2026-10-18T12:38:34.451Z RetatrutideCompare en 2026-10-18T12:38:34.451Z Safety of GLP-1 Agonists in Overweight Patients Undergoing Shoulder Surgery Clinical Trials, Retatrutide https://retacompare.com/news/updates-on-glp-1-agonists-and-eli-lilly-s-retatrutide-developments 2026-10-18T12:08:00.000Z RetatrutideCompare en 2026-10-18T12:08:00.000Z Updates on GLP-1 Agonists and Eli Lilly's Retatrutide Developments Market News, Retatrutide https://retacompare.com/news/fda-approval-status-of-retatrutide-for-weight-loss-expected-by-2026 2026-10-18T09:38:12.000Z RetatrutideCompare en 2026-10-18T09:38:12.000Z FDA Approval Status of Retatrutide for Weight Loss Expected by 2026 Market News, Retatrutide https://retacompare.com/news/glp-1-agonists-show-potential-in-obstructive-sleep-apnea-management 2026-10-17T21:45:52.000Z RetatrutideCompare en 2026-10-17T21:45:52.000Z GLP-1 Agonists Show Potential in Obstructive Sleep Apnea Management Clinical Trials, Retatrutide https://retacompare.com/news/black-market-retatrutide-implicated-in-fatalities 2026-10-17T18:51:00.000Z RetatrutideCompare en 2026-10-17T18:51:00.000Z Black Market Retatrutide Implicated in Fatalities Market News, Retatrutide https://retacompare.com/news/retatrutide-weight-loss-drug-updates-and-future-prospects 2026-10-17T18:07:09.000Z RetatrutideCompare en 2026-10-17T18:07:09.000Z Retatrutide Weight Loss Drug Updates and Future Prospects Market News, Retatrutide https://retacompare.com/news/fda-raises-concerns-over-unapproved-glp-1-drugs-for-weight-loss 2026-10-17T13:33:47.000Z RetatrutideCompare en 2026-10-17T13:33:47.000Z FDA Raises Concerns Over Unapproved GLP-1 Drugs for Weight Loss Market News, Retatrutide https://retacompare.com/news/retatrutide-developments-future-outlook-on-weight-loss-drug-by-2026 2026-10-17T11:25:12.000Z RetatrutideCompare en 2026-10-17T11:25:12.000Z Retatrutide Developments: Future Outlook on Weight Loss Drug by 2026 Market News, Retatrutide https://retacompare.com/news/retatrutide-shows-cardiovascular-biomarker-benefits-in-obesity-study 2026-10-17T10:51:04.886Z RetatrutideCompare en 2026-10-17T10:51:04.886Z Retatrutide Shows Cardiovascular Biomarker Benefits in Obesity Study Clinical Trials, Retatrutide